Author Archives: admin
The IPO Buzz: The Ticking of the Bio-IPO Clock
Today’s “hot” IPO sector is starting to show signs of age. But if you listen to the wind, changes are in the works.
IPO Traffic: Week Ending Feb. 7, 2014
The IPO Buzz: The Running of the Biotechs
IPO players are ready to join the running of the biotechs through the canyons of Wall Street this week. Eleven of the 14 IPOs that are on the calendar are biotechs. And last week’s traffic was dominated by – yes – biotechs. Four of the eight IPOs that were priced were from this sector. A couple scored opening-day moonshots.
IPO Traffic: Week Ending Jan. 31, 2014
The IPO Buzz: Red-Hot Bio-IPOs
The days of the biotech and biopharma companies are coming to Wall Street. Three of the six IPOs on this week’s calendar are bio-IPOs and eight – yes, eight – of next week’s 10 IPOs are bio-IPOs. The emergence of this industrial sector should not be surprising. It has been sizzling.
IPO Traffic: Week Ending Jan. 24, 2014
The IPO Buzz: An IPO Ticket to Ride
The Martin Luther King, Jr. Day Holiday shortens this week’s trading sessions to four days and pushes the IPO traffic back to the end of the week. But something happened on the way to market. The pricing of a billion-dollar deal was accelerated. The usual reason for acceleration is strong investor demand.
IPO Traffic: Week Ending Jan. 17, 2014
The IPO Buzz: Fast Traffic on the IPO Highway
This year’s IPO market got off to a fast start. On Tuesday morning, an amendment was posted on the U.S. Securities and Exchange Commission’s filing window announcing expected pricing terms for what proved to be 2014’s first IPO. The deal jumped onto the calendar for a Thursday evening pricing, started trading Friday morning, and popped for an opening-day gain of 12.6 percent. In the meantime, the SEC’s filing window started spitting out deal after deal plus pricing terms after pricing terms. By week’s end, the calendar had eight IPOs expecting to raise over $3.7 billion.